LISTENing to healthcare students: the impact of new library facilities on the quality of services
✍ Scribed by Graham C. Haldane
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 216 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1471-1834
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Following a low assessment of ‘Learning resources’ provision by the Quality Assurance Agency, the librarian of Homerton College, School of Health Studies commenced the LISTEN Project, a long‐term study to monitor the effects of planned interventions on the quality of library provision. Surveys of entry‐to‐register student nurses & midwives were conducted in 1999 and 2001 by extensive questionnaires, inviting Likert‐scaled and free text responses. Following a college relocation, students made greater than expected use of a new health studies library in Cambridge, and significantly less use of the local teaching hospital library. Using both a satisfaction index and a non‐parametric test of mean scores, student evaluation of library services in Cambridge significantly improved following relocation. The physical accommodation and location of library services remain important to healthcare students. Identifiable improvements to the quality of services, however, will overcome initial resistance to change. Education providers must ensure the best mix of physical and electronic services for students who spend much of their time on clinical placement.
📜 SIMILAR VOLUMES
This paper describes the epidemiological and demographic trends underpinning the current shift to primary health care heralded by the Community Care Act. It suggests that the health service is increasingly treating people suffering from long‐term disability. Hospitals no longer provide an appropriat
The absence of a unanimous, industry-specific definition of quality is, to a certain degree, impeding the progress of ongoing efforts to "modernize" the pharmaceutical industry. This work was predicated on requests by Dr. Woodcock (FDA) to re-define pharmaceutical quality in terms of risk by linking